Patents by Inventor Nobukazu Ono

Nobukazu Ono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STROKE DIAGNOSIS AND THERAPY ASSISTANCE SYSTEM, STROKE STATE INFORMATION PROVIDING DEVICE, AND STROKE STATE INFORMATION PROVIDING PROGRAM
    Publication number: 20240136062
    Abstract: [Problems] Provision of a system for assisting diagnosis/treatment of stroke which can easily provide supportive information so that the type of stroke can be determined appropriately and corresponding treatment strategy can be implemented. [Solutions] When the device for assisting diagnosis/treatment of stroke 101 acquires information of CT images, DWI, ADCmap, and MRA images indicating state of stroke from the device for providing information about state of stroke 103, it uses the acquired information of images and the information about laboratory findings to determine the type of stroke in a unit of stroke type determiner trained to use the predetermined information of images and the predetermined information about laboratory findings to determine the type of stroke corresponding thereto.
    Type: Application
    Filed: September 8, 2021
    Publication date: April 25, 2024
    Inventors: Nobutaka Hattori, Kazuo Yamashiro, Yuji Ueno, Nobukazu Miyamoto, Mika Asari, Kazuto Ono, Takashi Someda, Naoki Kitora, Yoshihiko Iwao, Keiichiro Takahashi
  • METHOD FOR EVALUATING PANCREATIC CANCER, PANCREATIC CANCER EVALUATING APPARATUS, PANCREATIC CANCER EVALUATING METHOD, PANCREATIC CANCER EVALUATING PROGRAM PRODUCT, PANCREATIC CANCER EVALUATING SYSTEM AND INFORMATION COMMUNICATION TERMINAL APPARATUS
    Publication number: 20210287802
    Abstract: A method of evaluating pancreatic cancer includes (I) an obtaining step of obtaining amino acid concentration data on a concentration value of an amino acid in blood collected from a subject to be evaluated, and (II) an evaluating step of evaluating a state of pancreatic cancer in the subject by calculating a value of a formula using the amino acid concentration data of the subject obtained at the obtaining step and the formula previously established for evaluating the state of pancreatic cancer, including an explanatory variable to be substituted with the concentration value of the amino acid.
    Type: Application
    Filed: May 4, 2021
    Publication date: September 16, 2021
    Applicant: Ajinomoto Co., Inc.
    Inventors: Nobukazu ONO, Atsuko SHINHARA, Takahiko MURAMATSU, Shinya KIKUCHI, Hiroshi YAMAMOTO, Koichi SHIRAISHI, Kazuhiro KATAYAMA, Nobuyasu FUKUTAKE, Masahiko HIGASHIYAMA, Shinichi OHKAWA, Makoto UENO, Yohei MIYAGI, Naoyuki OKAMOTO
  • EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
    Publication number: 20180017545
    Abstract: An evaluating method includes an evaluating step of evaluating a future risk of relapse of ulcerative colitis for a subject to be evaluated having ulcerative colitis in a remission phase using a concentration value of histidine, albumin, hemoglobin, or glutamic acid in blood of the subject.
    Type: Application
    Filed: September 13, 2017
    Publication date: January 18, 2018
    Applicant: AJINOMOTO CO., INC.
    Inventors: Tadakazu HISAMATSU, Takanori KANAI, Toshifumi HIBi, Nobukazu ONO, Akira IMAIZUMI, Masaki HASHIMOTO, Maiko MORI, Michihide Uo
  • Lung cancer evaluating apparatus, method, system, and program and recording medium therefor
    Patent number: 9664681
    Abstract: According to the method of evaluating lung cancer, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and a lung cancer state in the subject is evaluated based on the concentration value of at least one of Orn, Lys, ABA, Arg, Glu, His, Tau, Pro, Ala, Cit and Ile contained in the measured amino acid concentration data of the subject.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: May 30, 2017
    Assignee: Ajinomoto Co., Inc.
    Inventors: Akira Imaizumi, Nobukazu Ono, Ryosei Sakai, Toshihiko Ando, Naoyuki Okamoto, Fumio Imamura, Masahiko Higashiyama
  • METHOD OF EVALUATING PANCREATIC CANCER, PANCREATIC CANCER-EVALUATING APPARATUS, PANCREATIC CANCER-EVALUATING METHOD, PANCREATIC CANCER-EVALUATING PROGRAM PRODUCT, PANCREATIC CANCER-EVALUATING SYSTEM, AND INFORMATION COMMUNICATION TERMINAL APPARATUS
    Publication number: 20150254411
    Abstract: A method of evaluating pancreatic cancer includes (I) an obtaining step of obtaining amino acid concentration data on a concentration value of an amino acid in blood collected from a subject to be evaluated, and (II) an evaluating step of evaluating a state of pancreatic cancer in the subject by calculating a value of a formula using the amino acid concentration data of the subject obtained at the obtaining step and the formula previously established for evaluating the state of pancreatic cancer, including an explanatory variable to be substituted with the concentration value of the amino acid.
    Type: Application
    Filed: May 26, 2015
    Publication date: September 10, 2015
    Applicant: Ajinomoto Co., Inc.
    Inventors: Nobukazu Ono, Atsuko Shinhara, Takahiko Muramatsu, Shinya Kikuchi, Hiroshi Yamamoto, Koichi Shiraishi, Kazuhiro Katayama, Nobuyasu Fukutake, Masahiko Higashiyama, Shinichi Ohkawa, Makoto Ueno, Yohei Miyagi, Naoyuki Okamoto
  • METHOD OF EVALUATING IBD, AMINO ACID DATA PROCESSOR, AMINO ACID DATA-PROCESSING METHOD, AMINO ACID DATA-PROCESSING SYSTEM, AMINO-ACID DATA-PROCESSING PROGRAM AND RECORDING MEDIUM
    Publication number: 20100062413
    Abstract: According to the method of evaluating IBD of the present invention, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and an inflammatory bowel disease state in the subject is evaluated based on the measured amino acid concentration data of the subject.
    Type: Application
    Filed: July 23, 2009
    Publication date: March 11, 2010
    Inventors: TAKAHIKO MURAMATSU, AYATOSHI ANDOU, TOSHIFUMI HIBI, TADAKAZU HISAMATSU, SUSUMU OKAMOTO, RYOSEI SAKAI, NOBUKAZU ONO, MANABU SUZUKI, TOSHIHIKO ANDO, MASAKI HASHIMOTO
  • Lung cancer evaluating apparatus, method, system, and program and recording medium therefor
    Publication number: 20100017144
    Abstract: According to the method of evaluating lung cancer, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and a lung cancer state in the subject is evaluated based on the concentration value of at least one of Orn, Lys, ABA, Arg, Glu, His, Tau, Pro, Ala, Cit and Ile contained in the measured amino acid concentration data of the subject.
    Type: Application
    Filed: February 4, 2009
    Publication date: January 21, 2010
    Inventors: Akira Imaizumi, Nobukazu Ono, Ryosei Sakai, Toshihiko Ando, Naoyuki Okamoto, Fumio Imamura, Masahiko Higashiyama
  • METABOLIC SYNDROME EVALUATING APPARATUS, METHOD, SYSTEM, PROGRAM, AND RECORDING MEDIUM THEREFOR
    Publication number: 20090253116
    Abstract: According to the method of evaluating metabolic syndrome, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and the state of metabolic syndrome in the subject is evaluated based on the measured amino acid concentration data of the subject.
    Type: Application
    Filed: February 4, 2009
    Publication date: October 8, 2009
    Inventors: Mitsuo TAKAHASHI, Nobukazu ONO, Toshihiko ANDO, Akira OKANO, Minoru YAMAKADO
  • Method for treatment in gene therapy and use of guanine derivative therefor
    Patent number: 6331528
    Abstract: The present invention relates to a method for inhibiting cell growth whereby a thymidine kinase gene is introduced and expressed in a cell followed by administering a (−)-9-[1,S,2′R-bis(hydroxymethyl)cyclopropan-1′-yl]methylguanine in an amount sufficient to inhibit cell growth.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: December 18, 2001
    Assignee: Ajinomoto Co., Inc.
    Inventor: Nobukazu Ono